STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $6,000 | -66.7% | 3,000 | -51.3% | 0.00% | – |
| Q2 2021 | $18,000 | -94.7% | 6,156 | -95.0% | 0.00% | – |
| Q1 2021 | $341,000 | +11.4% | 123,406 | -2.3% | 0.00% | – |
| Q4 2020 | $306,000 | +500.0% | 126,281 | +422.4% | 0.00% | – |
| Q3 2020 | $51,000 | -94.7% | 24,175 | -90.6% | 0.00% | – |
| Q2 2020 | $971,000 | +21.5% | 257,099 | -39.2% | 0.00% | – |
| Q1 2020 | $799,000 | +462.7% | 422,711 | +523.8% | 0.00% | – |
| Q4 2019 | $142,000 | +305.7% | 67,766 | +355.9% | 0.00% | – |
| Q3 2019 | $35,000 | -16.7% | 14,865 | +14.9% | 0.00% | – |
| Q2 2019 | $42,000 | -36.4% | 12,941 | +72.5% | 0.00% | – |
| Q1 2018 | $66,000 | -45.9% | 7,503 | -55.3% | 0.00% | – |
| Q4 2017 | $122,000 | – | 16,802 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,376,039 | $47,309,000 | 51.34% |
| Lyon Street Capital, LLC | 3,182,149 | $28,162,000 | 9.07% |
| Opaleye Management Inc. | 1,590,000 | $14,071,000 | 4.02% |
| Broadfin Capital, LLC | 2,793,752 | $24,725,000 | 3.85% |
| Vivo Capital, LLC | 1,918,132 | $16,975,000 | 2.40% |
| ARMISTICE CAPITAL, LLC | 3,372,000 | $29,842,000 | 2.28% |
| PRECEPT MANAGEMENT LLC | 470,000 | $4,160,000 | 1.73% |
| NEA Management Company, LLC | 4,141,308 | $36,651,000 | 1.63% |
| Harvest Capital Strategies LLC | 825,000 | $7,301,000 | 1.14% |
| Granite Point Capital Management, L.P. | 567,895 | $5,026,000 | 0.49% |